Democratic presidential candidate Hillary Clinton is the newest political figure urging Mylan to voluntarily lower the price of its life-saving EpiPen injection, reports Reuters.
The medication, which can cost up to $700, has increased in price by more than 400 percent since 2007.
"That's outrageous — and it's just the latest troubling example of a company taking advantage of its consumers," Ms. Clinton said in a statement. "It's wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them."
Ms. Clinton joins a group of senators vocalizing their unfavorable opinions of the price hike. Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) recently wrote a letter to Mylan, asking the company to explain the price hikes. Senator Amy Klobuchar (D-Minn.) even called for a federal investigation of the Canonsburg, Pa.-based company's pricing practices.
The White House took a more cautious approach when addressing the topic, criticizing the overall issue of rising drug costs.
"I will observe, however, that pharmaceutical companies that often try to portray themselves as the inventors of life-saving medication often do real damage to their reputation by being greedy and jacking up prices in a way that victimizes," said Josh Earnest, a spokesman for the White House, at a news briefing.